From 1 January 2023, the ongoing maintenance of the AIP initiative is transitioning to us from the Australian Commission on Quality and Safety in Health Care.
The commission's AIP resources were last updated in December 2022. We will review AIP resources after the transition.
If you require assistance with the AIP initiative (including any requests for us to consider medicines for exclusion from AIP requirements) please email us.
AIP is part of a wider government initiative to ensure consistent information about prescription medicines. Learn more about the program and why it is important.
Learn about what is, and what is not an active ingredient in prescription medicines.
Active ingredient prescribing (AIP) is mandatory for prescription medication listen on the Pharmaceutical Benefits Schedule (PBS) and the Repatriation Schedule of Pharmaceutical Benefits (RPBS).
The List of Excluded Medicinal Items (LEMI) and the List of Medicines for Brand Consideration (LMBC) help support prescribers to prescribe medicines by the active ingredient with best practice guidance for specification of brand.